Two doses of a simple tuberculosis vaccine after surgery support the immune system in fighting cancer cells and could significantly improve treatment outcomes for the most common form of bladder cancer, according to a pilot study involving 40 patients. Initial results of the RUTIVAC-1 study were presented at EAU25.
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Glomerulonephritis: IgA nephropathy
Pathogenesis-based and nephroprotective therapeutic approaches
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Internal thoracoscopy